content top

Corticosteroid Intravitreal Treatment in AMD Patient with a Recent Stroke

ABSTRACT Introduction: Anti-angiogenic treatment with anti-vascular endothelial growth factor (anti-VEGF) for patients with exudative neovascular age-related macular degeneration (AMD) is the most effective in slowing the progression of visual loss and is first choice therapy. The safety data in patients with cerebrovascular accidents (CVA) in the last 6 months is limited since this condition has been considered as an exclusion criterion in...

Read More

Alternative Diffuse DME Treatment: Laser Photostimulation versus Topical Medical Therapy

Introduction: The standard first-line treatment for diffuse diabetic macular edema (DDME) is intravitreal injections. Although considered safer and more effective than laser, these drugs may have serious ocular and systemic complications. Recent research of the pharmacological properties of Nepafenac, found that this drug could reach the retina in sufficient concentrations to produce beneficial effects. We evaluated the efficacy of...

Read More

Prevention of Endophthalmitis Following Intravitreal Anti-VEGF Injection

Vladimir Poposki_SCIENTIFIC POSTER 2015 Introduction: The endophthalmitis is a devastating complication of intravitreal injection (IVI) procedure. Topical antibiotics are used by consensus and protocol, because of supposed advantage of its use in the reduction of conjunctival bacterial growth. However, this benefit is controversial. Many studies concluded that they do not alter the incidence nor reduce the risk of endophthalmitis. Even...

Read More
content top